- Home
- RLGT vs PGEN Comparison
RLGT vs PGEN Comparison
Compare RLGT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- PGEN
- Stock Information
- Founded
- RLGT 2001
- PGEN 1998
- Country
- RLGT United States
- PGEN United States
- Employees
- RLGT N/A
- PGEN N/A
- Industry
- RLGT Oil Refining/Marketing
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- PGEN Health Care
- Exchange
- RLGT Nasdaq
- PGEN Nasdaq
- Market Cap
- RLGT 295.7M
- PGEN 344.0M
- IPO Year
- RLGT N/A
- PGEN N/A
- Fundamental
- Price
- RLGT $5.97
- PGEN $1.50
- Analyst Decision
- RLGT
- PGEN Strong Buy
- Analyst Count
- RLGT 0
- PGEN 4
- Target Price
- RLGT N/A
- PGEN $7.33
- AVG Volume (30 Days)
- RLGT 225.0K
- PGEN 1.4M
- Earning Date
- RLGT 05-08-2025
- PGEN 05-13-2025
- Dividend Yield
- RLGT N/A
- PGEN N/A
- EPS Growth
- RLGT 32.26
- PGEN N/A
- EPS
- RLGT 0.29
- PGEN N/A
- Revenue
- RLGT $858,699,000.00
- PGEN $3,925,000.00
- Revenue This Year
- RLGT $12.86
- PGEN $189.12
- Revenue Next Year
- RLGT $5.75
- PGEN $1,093.07
- P/E Ratio
- RLGT $20.33
- PGEN N/A
- Revenue Growth
- RLGT N/A
- PGEN N/A
- 52 Week Low
- RLGT $4.83
- PGEN $0.65
- 52 Week High
- RLGT $7.94
- PGEN $2.17
- Technical
- Relative Strength Index (RSI)
- RLGT 47.99
- PGEN 49.93
- Support Level
- RLGT $5.61
- PGEN $1.33
- Resistance Level
- RLGT $6.13
- PGEN $1.65
- Average True Range (ATR)
- RLGT 0.25
- PGEN 0.14
- MACD
- RLGT 0.05
- PGEN 0.03
- Stochastic Oscillator
- RLGT 75.88
- PGEN 72.22
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.